Clinical Trial Utilizing BioAtla’s Conditionally Active Biologics In CAR-T Candidates For Solid Tumors To Be … – Markets Insider
|
Clinical Trial Utilizing BioAtla’s Conditionally Active Biologics In CAR–T Candidates For Solid Tumors To Be …
Markets Insider SAN DIEGO, Jan. 8, 2018 /PRNewswire/ — BioAtla, LLC, a global biotechnology company focused on the development of Conditionally Active Biologic (CAB) protein therapeutics, announced today that Shanghai Sinobioway Sunterra Biotechnology, a partner of … |
|
Donor found for girl’s stem–cell transplant
Times Colonist Cheryl and Ken Taschuk are grateful their 12-year-old grandniece will receive a stem–cell transplant after a widespread effort turned up a donor. Supporters of Alex Pasichnyk, a resident of St. Albert, Alta., have been trying to find a compatible bone … |
